AAM
AMPH icon

Advisors Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Advisors Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-399
Closed -$14.8K – 1500
2024
Q4 		$14.8K Sell
399
-474
-54% -$21.7K ﹤0.01% 1393
2024
Q3 		$42.4K Sell
873
-53
-6% -$2.33K ﹤0.01% 1315
2024
Q2 		$37K Sell
926
-4
-0.4% -$166 ﹤0.01% 1321
2024
Q1 		$40.8K Buy
930
+87
+10% +$4.49K ﹤0.01% 1308
2023
Q4 		$52.1K Buy
843
+401
+91% +$21.1K ﹤0.01% 1284
2023
Q3 		$20.3K Buy
+442
New +$24.1K ﹤0.01% 1359

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisors Asset Management's AMPH Position: Q1 2025 in Review

Advisors Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 399 shares — an estimated $14.8K sold.

Advisors Asset Management first reported a position in AMPH in Q3 2023 and held it in 6 quarters. The position peaked at $52.1K in Q4 2023. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

  • Advisors Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Advisors Asset Management sold 399 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $14.8K.
  • Advisors Asset Management first reported a position in Amphastar Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • Advisors Asset Management's Amphastar Pharmaceuticals position peaked at $52.1K in Q4 2023.
  • 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on Advisors Asset Management's 13F filing for Q1 2025, filed 15 May 2025.